Astera Labs (NASDAQ:ALAB) CEO Sells 139,951 Shares

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan sold 139,951 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $200.16, for a total transaction of $28,012,592.16. Following the sale, the chief executive officer owned 3,929,183 shares of the company’s stock, valued at $786,465,269.28. This represents a 3.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jitendra Mohan also recently made the following trade(s):

• On Monday, April 20th, Jitendra Mohan sold 10,188 shares of Astera Labs stock. The shares were sold at an average price of $175.45, for a total transaction of $1,787,484.60.
• On Friday, April 17th, Jitendra Mohan sold 325,693 shares of Astera Labs stock. The stock was sold at an average price of $172.14, for a total transaction of $56,064,793.02.
• On Wednesday, April 15th, Jitendra Mohan sold 2,967 shares of Astera Labs stock. The shares were sold at an average price of $174.60, for a total transaction of $518,038.20.
• On Friday, April 10th, Jitendra Mohan sold 123,750 shares of Astera Labs stock. The shares were sold at an average price of $149.68, for a total transaction of $18,522,900.00.
• On Tuesday, March 17th, Jitendra Mohan sold 157,500 shares of Astera Labs stock. The stock was sold at an average price of $131.58, for a total value of $20,723,850.00.
• On Tuesday, February 17th, Jitendra Mohan sold 94,971 shares of Astera Labs stock. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51.

Astera Labs Trading Up 3.8%

Shares of Astera Labs stock traded up $7.56 on Monday, hitting $207.35. The stock had a trading volume of 5,600,886 shares, compared to its average volume of 6,128,509. The stock has a market cap of $35.54 billion, a price-to-earnings ratio of 147.99, a P/E/G ratio of 3.30 and a beta of 3.35. Astera Labs, Inc. has a 52-week low of $76.53 and a 52-week high of $262.90. The company’s 50 day moving average price is $143.77 and its 200 day moving average price is $153.99.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.07. The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm’s quarterly revenue was up 93.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.33 EPS. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Analysts predict that Astera Labs, Inc. will post 1.48 EPS for the current fiscal year.

Institutional Investors Weigh In On Astera Labs

Hedge funds have recently modified their holdings of the stock. Nordea Investment Management AB acquired a new stake in shares of Astera Labs in the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC acquired a new position in Astera Labs during the third quarter worth $1,876,000. Numerai GP LLC grew its holdings in Astera Labs by 153.1% during the third quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after acquiring an additional 7,992 shares during the period. Handelsbanken Fonder AB raised its position in Astera Labs by 289.5% in the third quarter. Handelsbanken Fonder AB now owns 126,200 shares of the company’s stock worth $24,710,000 after acquiring an additional 93,800 shares in the last quarter. Finally, Paragon Advisors LLC purchased a new position in Astera Labs in the third quarter worth $1,829,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

ALAB has been the topic of a number of recent research reports. JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Royal Bank Of Canada raised their price objective on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 6th. Roth Mkm restated a “buy” rating and issued a $275.00 price objective on shares of Astera Labs in a research note on Wednesday, May 6th. TD Cowen upped their target price on shares of Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a report on Wednesday, May 6th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $270.00 target price on shares of Astera Labs in a research note on Wednesday, May 6th. Fifteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $229.65.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.